UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036833
Receipt number R000041961
Scientific Title Aesthetics medical education program construction by department of Plastic and Aesthetic Surgery Kitasato University school of medicine -focusing on filler treatment-
Date of disclosure of the study information 2019/05/23
Last modified on 2019/05/23 18:23:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Aesthetics medical education program construction by department of Plastic and Aesthetic Surgery Kitasato University school of medicine -focusing on filler treatment-

Acronym

Aesthetics medical education program construction by department of Plastic and Aesthetic Surgery Kitasato University school of medicine -focusing on filler treatment-

Scientific Title

Aesthetics medical education program construction by department of Plastic and Aesthetic Surgery Kitasato University school of medicine -focusing on filler treatment-

Scientific Title:Acronym

Aesthetics medical education program construction by department of Plastic and Aesthetic Surgery Kitasato University school of medicine -focusing on filler treatment-

Region

Japan


Condition

Condition

aging face

Classification by specialty

Aesthetic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Conduct doctor's education centering on filler therapy.Development of effective treatment using MHLW approved products and improvement of filler technology, and we will work on this educational program with the aim of developing medical care with high safety.

Basic objectives2

Others

Basic objectives -Others

Providing as a university hospital information and research that maximizes doctor's knowledge and skills in cosmetic medicine.To this end, invite famous foreign doctors and share knowledge.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Invited foreign doctors who are famous for filler therapy,Hold an injection seminar.Once every four months, about three times a year,Provide information and research opportunities that bring the doctor's knowledge and skills to the highest level.

Key secondary outcomes

Skin findings, analysis of stains and wrinkles on the skin using digital camera images, and survey subjects (monitor) questionnaires.Each injection before injection, once every two weeks after injection.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

Duration of intervention for individual subjects.Only once at the time of the seminar.Dosage (until 1 to 20 cc of hyaluronic acid, 100 units of Botox)Time (about 15 minutes to 1 hour in one treatment)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who are judged to have wrinkles or sagging in Department of Plastic and Aesthetic Surgery Kitasato University kitasato Institute Hospital and Kitasato University,school of medicine and wish to treat them.
Patients who have agreed as research subjects (monitors) of the seminar according to this program.

Key exclusion criteria

If you have a generalized muscle disease
Those who are pregnant or may be pregnant, and who are nursing
If you have used allergy to this drug before or if you are allergic
If you have chronic respiratory disease such as asthma, or if you have glaucoma
Person who has a history of hypersensitivity to the ingredients of this product or to the amide type local anesthetic
Persons who have a history of hypersensitivity to proteins derived from gram-positive bacteria

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Takeda

Organization

Kitasato university,school of medicine

Division name

DEPARTMENT OF Plastic & Aesthetic Surgery

Zip code

2520374

Address

1-15-1 Kitasato,minami-ku,Sagamihara-city,Kanagawa

TEL

0427789074

Email

takeda@kitasato-u.ac.jp


Public contact

Name of contact person

1st name yoshika
Middle name
Last name sugimoto

Organization

KITASATO UNIVERSITY,SCHOOL OF MEDICINE

Division name

DEPARTMENT OF Plastic & Aesthetic Surgery

Zip code

2520374

Address

1-15-1 Kitasato,minami-ku,Sagamihara-city,Kanagawa

TEL

0427789074

Homepage URL


Email

yoshika@yahoo.co.jp


Sponsor or person

Institute

KITASATO UNIVERSITY,SCHOOL OF MEDICINE
KITASATO UNIVERSITY,KITASATO Insutitute Hospital

Institute

Department

Personal name



Funding Source

Organization

allergan.jp
galderma.jp

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KITASATO UNIVERSITY,SCHOOL OF MEDICINE

Address

1-15-1 Kitasato,minami-ku,Sagamihara-city,Kanagawa

Tel

0427789074

Email

yoshika@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 02 Month 20 Day

Date of IRB

2019 Year 04 Month 17 Day

Anticipated trial start date

2019 Year 07 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 05 Month 23 Day

Last modified on

2019 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041961


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name